Entity Common Stock, Shares Outstanding of Coherus Oncology, Inc. from 30 Nov 2014 to 28 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Coherus Oncology, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Nov 2014 to 28 Feb 2026.
  • Coherus Oncology, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 28 Feb 2026 was 149,889,902, a 29% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Coherus Oncology, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 149,889,902 +33,956,626 +29% 28 Feb 2026 10-K 09 Mar 2026 2025 FY
Q3 2025 120,871,013 +5,657,606 +4.9% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 116,227,275 +1,018,692 +0.88% 31 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 115,933,276 +1,207,536 +1.1% 30 Apr 2025 10-Q 12 May 2025 2025 Q1
Q3 2024 115,213,407 +3,849,255 +3.5% 31 Oct 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 115,208,583 +20,740,090 +22% 31 Jul 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 114,725,740 +34,172,010 +42% 30 Apr 2024 10-Q 09 May 2024 2024 Q1
Q3 2023 111,364,152 +33,586,214 +43% 31 Oct 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 94,468,493 +16,743,904 +22% 31 Jul 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 80,553,730 +3,130,760 +4% 30 Apr 2023 10-Q 08 May 2023 2023 Q1
Q3 2022 77,777,938 +992,507 +1.3% 31 Oct 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 77,724,589 +1,244,437 +1.6% 31 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 77,422,970 +1,670,492 +2.2% 30 Apr 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 77,275,299 +4,481,639 +6.2% 31 Jan 2022 10-K 23 Feb 2022 2021 FY
Q3 2021 76,785,431 +4,737,419 +6.6% 05 Nov 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 76,480,152 +5,009,715 +7% 30 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 75,752,478 +4,839,856 +6.8% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 72,793,660 +2,169,295 +3.1% 31 Jan 2021 10-K 25 Feb 2021 2020 FY
Q3 2020 72,048,012 +1,918,672 +2.7% 31 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 71,470,437 +1,706,469 +2.4% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 70,912,622 +1,542,165 +2.2% 30 Apr 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 70,624,365 31 Jan 2020 10-K 27 Feb 2020 2019 FY
Q3 2019 70,129,340 +2,104,342 +3.1% 31 Oct 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 69,763,968 +1,943,141 +2.9% 31 Jul 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 69,370,457 +8,207,315 +13% 30 Apr 2019 10-Q 09 May 2019 2019 Q1
Q3 2018 68,024,998 +10,079,568 +17% 31 Oct 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 67,820,827 +16,474,140 +32% 31 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 61,163,142 +9,875,025 +19% 30 Apr 2018 10-Q 10 May 2018 2018 Q1
Q3 2017 57,945,430 +14,292,687 +33% 31 Oct 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 51,346,687 +7,965,860 +18% 31 Jul 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 51,288,117 +12,146,596 +31% 28 Apr 2017 10-Q 08 May 2017 2017 Q1
Q3 2016 43,652,743 +4,760,093 +12% 31 Oct 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 43,380,827 +5,082,957 +13% 31 Jul 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 39,141,521 +1,300,174 +3.4% 30 Apr 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 39,103,426 +5,845,448 +18% 31 Jan 2016 10-K 29 Feb 2016 2015 FY
Q3 2015 38,892,650 31 Oct 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 38,297,870 31 Jul 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 37,841,347 30 Apr 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 33,257,978 30 Nov 2014 10-Q 15 Dec 2014 2014 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.